We are live on !
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $17.4M invested in Tonix Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
3.81% more ownership
Funds ownership: 42.44% → 46.25% (+3.8%)
63% less call options, than puts
Call options by funds: $55K | Put options by funds: $150K
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $4.08M
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$55K
Puts
$150K
Net Calls
-$95K
Net Calls Change
-$174K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deerfield Management
New York
|
-$3.17M |
| 2 |
Lombard Odier Asset Management (USA)
New York
|
-$559K |
| 3 |
Integre Asset Management
New York
|
-$139K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$117K |
| 5 |
Alambic Investment Management
Belvedere,
California
|
-$82K |